InflaRx (IFRX) EPS (Basic) (2022 - 2025)
Historic EPS (Basic) for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to -$1.11.
- InflaRx's EPS (Basic) fell 34811.24% to -$1.11 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.11, marking a year-over-year decrease of 34811.24%. This contributed to the annual value of -$6.47 for FY2024, which is 67066.98% down from last year.
- According to the latest figures from Q3 2025, InflaRx's EPS (Basic) is -$1.11, which was down 34811.24% from -$35406.9 recorded in Q2 2025.
- In the past 5 years, InflaRx's EPS (Basic) ranged from a high of $10309.3 in Q1 2023 and a low of -$36349.2 during Q2 2024
- Its 4-year average for EPS (Basic) is -$5536.9, with a median of -$0.25 in 2024.
- Within the past 5 years, the most significant YoY rise in InflaRx's EPS (Basic) was 307801038.36% (2023), while the steepest drop was 61761.09% (2023).
- InflaRx's EPS (Basic) (Quarter) stood at -$0.17 in 2022, then tumbled by 32.92% to -$0.22 in 2023, then tumbled by 473.73% to -$1.28 in 2024, then increased by 12.97% to -$1.11 in 2025.
- Its EPS (Basic) was -$1.11 in Q3 2025, compared to -$35406.9 in Q2 2025 and -$0.2 in Q1 2025.